XML 39 R32.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Significant Expense Categories Provided to CODM

The following table is representative of the significant expense categories regularly provided to the CODM when managing the Company’s single reportable segment:

 

 

Three months ended
June 30,

 

 

2025

 

 

2024

 

Revenues(1)

 

$

316

 

 

$

468

 

Less:

 

 

 

 

 

 

Cost of revenues

 

 

170

 

 

 

124

 

R&D costs(2)

 

 

739

 

 

 

545

 

G&A costs(3)

 

 

1,387

 

 

 

1,233

 

Personnel costs(4)

 

 

2,961

 

 

 

1,727

 

Other segment items(5)

 

 

87

 

 

 

252

 

Net loss

 

$

(5,028

)

 

$

(3,413

)

 

 

Six Months Ended
June 30,

 

 

2025

 

 

2024

 

Revenues(1)

 

$

697

 

 

$

1,016

 

Less:

 

 

 

 

 

 

Cost of revenues

 

 

276

 

 

 

343

 

R&D costs(2)

 

 

1,225

 

 

 

1,374

 

G&A costs(3)

 

 

2,788

 

 

 

2,648

 

Personnel costs(4)

 

 

5,983

 

 

 

3,565

 

Other segment items(5)

 

 

464

 

 

 

557

 

Net loss

 

$

(10,039

)

 

$

(7,471

)

 

(1) Includes Contract Manufacturing and Clinical Trial revenue

(2) Includes Clinical Development, Research & Discovery, CMC

(3) Includes Executive, Finance, Legal, Business Operations

(4) Includes compensation, benefits and equity-based compensation

(5) Includes depreciation and amortization, (interest income) and other specific charges